Literature DB >> 1567459

Staurosporine is a potent inhibitor of p34cdc2 and p34cdc2-like kinases.

D M Gadbois1, J R Hamaguchi, R A Swank, E M Bradbury.   

Abstract

We previously demonstrated that nontransformed cells arrest in the G1 phase of the cell cycle when treated with low concentrations (21 nM) of staurosporine (1). Both normal and transformed cells are blocked in the G2 phase of the cell cycle when treated with higher concentrations (160 nM) of staurosporine (1,2). In the present study, we show that staurosporine inhibits the activity of fractionated p34cdc2 and p34cdc2-like kinases with IC50 values of 4-5 nM. We propose that the G2 phase arrest in the cell cycle caused by staurosporine is due, at least in part, to the inhibition of the p34cdc2 kinases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1567459     DOI: 10.1016/0006-291x(92)91160-r

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  25 in total

Review 1.  Endoreduplication in higher plants.

Authors:  J Joubès; C Chevalier
Journal:  Plant Mol Biol       Date:  2000-08       Impact factor: 4.076

2.  Stimulatory effect of reconstituted basement membrane components (matrigel) on the colony formation of a panel of human lung cancer cell lines in soft agar.

Authors:  S Yoshida; E Shimizu; T Ogura; M Takada; S Sone
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

Review 3.  The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer.

Authors:  Katrien Vermeulen; Dirk R Van Bockstaele; Zwi N Berneman
Journal:  Cell Prolif       Date:  2003-06       Impact factor: 6.831

4.  Decreased accumulation and dephosphorylation of the mitosis-specific form of nucleophosmin/B23 in staurosporine-induced chromosome decondensation.

Authors:  Y Y Lu; C Y Lam; B Y Yung
Journal:  Biochem J       Date:  1996-07-01       Impact factor: 3.857

5.  Inactivation of Cdk1/Cyclin B in metaphase-arrested mouse FT210 cells induces exit from mitosis without chromosome segregation or cytokinesis and allows passage through another cell cycle.

Authors:  James R Paulson
Journal:  Chromosoma       Date:  2007-01-26       Impact factor: 4.316

6.  A myosin V inhibitor based on privileged chemical scaffolds.

Authors:  Kabirul Islam; Harvey F Chin; Adrian O Olivares; Lauren P Saunders; Enrique M De La Cruz; Tarun M Kapoor
Journal:  Angew Chem Int Ed Engl       Date:  2010-11-02       Impact factor: 15.336

7.  RNA-dependent phosphorylation of a nuclear RNA binding protein.

Authors:  P A Fung; R Labrecque; T Pederson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

Review 8.  Selectivity and potency of cyclin-dependent kinase inhibitors.

Authors:  Jayalakshmi Sridhar; Nagaraju Akula; Nagarajan Pattabiraman
Journal:  AAPS J       Date:  2006-03-24       Impact factor: 4.009

9.  Modulation of cyclin transcript levels in cultured cells of Arabidopsis thaliana.

Authors:  R A Fuerst; R Soni; J A Murray; K Lindsey
Journal:  Plant Physiol       Date:  1996-11       Impact factor: 8.340

10.  Multiple kinase arrest points in the G1 phase of nontransformed mammalian cells are absent in transformed cells.

Authors:  D M Gadbois; H A Crissman; R A Tobey; E M Bradbury
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.